358 related articles for article (PubMed ID: 37751026)
1. Copper in Cancer: from transition metal to potential target.
Fang C; Peng Z; Sang Y; Ren Z; Ding H; Yuan H; Hu K
Hum Cell; 2024 Jan; 37(1):85-100. PubMed ID: 37751026
[TBL] [Abstract][Full Text] [Related]
2. Targeting cuproplasia and cuproptosis in cancer.
Tang D; Kroemer G; Kang R
Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
[TBL] [Abstract][Full Text] [Related]
3. Cuproptosis: Harnessing Transition Metal for Cancer Therapy.
Wang W; Mo W; Hang Z; Huang Y; Yi H; Sun Z; Lei A
ACS Nano; 2023 Oct; 17(20):19581-19599. PubMed ID: 37820312
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis: mechanisms and links with cancers.
Xie J; Yang Y; Gao Y; He J
Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.
Gao J; Wu X; Huang S; Zhao Z; He W; Song M
Redox Biol; 2023 Nov; 67():102891. PubMed ID: 37734229
[TBL] [Abstract][Full Text] [Related]
6. Copper metabolism as a unique vulnerability in cancer.
Shanbhag VC; Gudekar N; Jasmer K; Papageorgiou C; Singh K; Petris MJ
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118893. PubMed ID: 33091507
[TBL] [Abstract][Full Text] [Related]
7. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
Lin Y; Yuan M; Wang G
J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
[TBL] [Abstract][Full Text] [Related]
8. Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies.
Wang X; Zhou M; Liu Y; Si Z
Cancer Lett; 2023 May; 561():216157. PubMed ID: 37011869
[TBL] [Abstract][Full Text] [Related]
9. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications.
Tarin M; Babaie M; Eshghi H; Matin MM; Saljooghi AS
J Transl Med; 2023 Oct; 21(1):745. PubMed ID: 37864163
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
Liu X; Luo B; Wu X; Tang Z
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
[TBL] [Abstract][Full Text] [Related]
11. Copper homeostasis: Emerging target for cancer treatment.
Li Y
IUBMB Life; 2020 Sep; 72(9):1900-1908. PubMed ID: 32599675
[TBL] [Abstract][Full Text] [Related]
12. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.
Bian C; Zheng Z; Su J; Chang S; Yu H; Bao J; Xin Y; Jiang X
Front Pharmacol; 2023; 14():1271613. PubMed ID: 37767404
[TBL] [Abstract][Full Text] [Related]
13. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
[TBL] [Abstract][Full Text] [Related]
14. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies.
Yang S; Li Y; Zhou L; Wang X; Liu L; Wu M
Cell Death Discov; 2024 Jan; 10(1):25. PubMed ID: 38218941
[TBL] [Abstract][Full Text] [Related]
15. Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics.
Park KC; Fouani L; Jansson PJ; Wooi D; Sahni S; Lane DJ; Palanimuthu D; Lok HC; Kovačević Z; Huang ML; Kalinowski DS; Richardson DR
Metallomics; 2016 Sep; 8(9):874-86. PubMed ID: 27334916
[TBL] [Abstract][Full Text] [Related]
16. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
17. Regulatory roles of copper metabolism and cuproptosis in human cancers.
Wang Z; Jin D; Zhou S; Dong N; Ji Y; An P; Wang J; Luo Y; Luo J
Front Oncol; 2023; 13():1123420. PubMed ID: 37035162
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis in lung cancer: mechanisms and therapeutic potential.
Li Q; Wang T; Zhou Y; Shi J
Mol Cell Biochem; 2023 Jul; ():. PubMed ID: 37480450
[TBL] [Abstract][Full Text] [Related]
19. Copper Homeostasis Based on Cuproptosis-Related Signature Optimizes Molecular Subtyping and Treatment of Glioma.
Zhang S; Yu H; Sun S; Fan X; Bi W; Li S; Wang W; Fang Z; Chen X
Mol Neurobiol; 2023 Dec; ():. PubMed ID: 38151613
[TBL] [Abstract][Full Text] [Related]
20. Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma.
Hu Q; Wang R; Ma H; Zhang Z; Xue Q
Front Oncol; 2022; 12():922332. PubMed ID: 36003780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]